• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Wednesday 09/26/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

pulmonary hypertension

  • 12:08 PM

    No Serious Adverse Events Related to Treatment with Nitric Oxide Reported Compelling Preliminary Data on Key Secondary Endpoint of 6-Minute Walk NEW YORK, Nov. 27, 2017, AITB, (GLOBE NEWSWIRE) — AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious lung infections and pulmonary hypertension, today announced that preliminary results from its NO-NTM Phase 2 study in Nontuberculous Mycobacteria (NTM) targeting patients suffering from Mycobacterium Abscessus Complex (MABSC)

    Read more
  • 6:17 PM

    VAL-D’OR, QUEBEC, Feb 23, 2015 (Marketwired via COMTEX) — Metanor Resources Inc. (“Metanor”) (TSX VENTURE: MTO) announces that an extraordinary resolution (the “Resolution”) has been approved by the holders of over 66 2/3 % of the aggregate outstanding principal amount ($10.0 million) of the Subordinated Secured Convertible Debentures, issued August 22, 2012, (the “Debentures”), as required under the debenture indenture, which extends the maturity date of the Debentures by 24 months, to August 22, 2017, conditional upon an equity financing

    Read more
Public Wire Banner